PA · Northeast
Philadelphia venture capital & startups
Philadelphia software and Penn cell therapy — dbt Labs, Crossbeam, Timbucktoo, Tmunity, Wealthmore.
Philadelphia’s directory signal is software scale (dbt Labs, Crossbeam) plus Penn Medicine cell-therapy history (Tmunity) and smaller a16z TxO bets (Timbucktoo, Wealthmore). Local fund HQ pages are empty; First Round is SF HQ in our data.
Aliases: Philadelphia, Philly, University City, Camden NJ. Startups matched by hq (Timbucktoo) plus curated IDs when Penn/Philly association is clear (Tmunity). Funds matched by fund.location only.
Venture firms in Philadelphia
Matched from fund headquarters in our directory (alias-based). Dual-HQ firms may appear in more than one city.
| Firm | HQ (directory) | Leads |
|---|---|---|
| Andreessen Horowitz | — | |
| Sequoia Capital | — | |
| Redpoint Ventures | — | |
| Kleiner Perkins | — | |
| Define Ventures | — | |
| F-Prime Capital | — |
Startups we cover in Philadelphia
Matched from startup hq fields. Many profiles still lack HQ — curated lists
in editorial notes fill gaps when verified.
| Startup | One-liner | HQ |
|---|---|---|
| dbt Labs | — | |
| Crossbeam | — | |
| Timbucktoo | — | |
| Tmunity Therapeutics | — | |
| Wealthmore | — |
Coverage gaps
-
Active University City / Penn cell-gene therapy companies beyond Tmunity
Tmunity is acquired/exited in our status field — founders need living peers (Cabaletta-class, Spark-adjacent lineage) that we have not shipped as /startup/ pages.
-
CHOP / Penn digital health and diagnostics startups
Baseline thesis includes digital health; almost none have structured profiles with investors and whyInteresting yet.
-
Local Philly seed funds and First Round Capital history
First Round is listed as San Francisco HQ in our fund JSON — not a Philly HQ match. Regional seed (BioAdvance-class, university angels) lack /fund/ pages.
-
Edtech and enterprise software around Drexel/Temple
Secondary Philly cluster; not represented in curated startup coverage today.
Related reading
Philadelphia FAQs
Practical answers for founders researching this investor.